Illumina CEO resigns

Francis deSouza, CEO of San Diego-based biotech company Illumina, stepped down from the role June 11 and will be an adviser through July. 

Advertisement

Charles Dadswell, senior vice president and general counsel, is now the interim CEO, according to a company news release. 

The board of directors accepted Mr. deSouza’s resignation after investor Carl Icahn critiqued the company over its Grail acquisition — which the Federal Trade Commission ordered to be divested — according to CNBC.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.